Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
APN:JSE
Aspen Pharmacare Holdings Ltd
13.900,00 ZAC
-1,16%
(-163,00) 1D
30 apr, 17:02:52 GMT+2  ·   ZAC
All symbols
SymbolPriceChange% Change
Generating top insights for APN...
Açın
13.941,00 ZAC
High
14.200,00 ZAC
Low
13.870,00 ZAC
Mkt. cap
62,03 mlrd
Avg. vol.
1,12 mln
Volume
1,84 mln
Dividend
1,52%
Quarterly dividend
52,75 ZAC
Ex dividend date
1 okt 2025
52-wk high
14.458,00 ZAC
52-wk low
9.070,00 ZAC
EPS
-4,51 ZAC
Shares outstanding
446,25 mln
No. of employees
9K
News stories
From sources across the web
Profile
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
About Aspen Pharmacare Holdings Ltd
CEOStephen Saad
Employees9,34K
Founded1850
HeadquartersDurban, KwaZulu-Natal, Cənub Afrika
SectorPharmaceutical industry
Websiteaspenpharma.com
Last report
11 fev 2026
Fiscal Period
Q2 2026
Normalized EPS / Estimate
-/ -ZAR
Revenue / Estimate
8,54 mlrd/ (- est.)ZAR
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in ZAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ZAR
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
10,70 mlrd
10,70 mlrd
8,54 mlrd
8,54 mlrd
Cost of goods sold
6,40 mlrd
6,40 mlrd
4,81 mlrd
4,81 mlrd
Cost of revenue
6,40 mlrd
6,40 mlrd
4,81 mlrd
4,81 mlrd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,79 mlrd
2,79 mlrd
2,17 mlrd
2,17 mlrd
Operating expense
2,75 mlrd
2,75 mlrd
2,82 mlrd
2,82 mlrd
Total operating expenses
9,15 mlrd
9,15 mlrd
7,63 mlrd
7,63 mlrd
Operating income
1,55 mlrd
1,55 mlrd
910,00 mln
910,00 mln
Other non operating income
-150,00 mln
-150,00 mln
-9,50 mln
-9,50 mln
EBT including unusual items
-1,65 mlrd
-1,65 mlrd
577,50 mln
577,50 mln
EBT excluding unusual items
1,12 mlrd
1,12 mlrd
577,50 mln
577,50 mln
Income tax expense
81,50 mln
81,50 mln
144,50 mln
144,50 mln
Effective tax rate
-4,93%
-4,93%
25,02%
25,02%
Other operating expenses
-39,50 mln
-39,50 mln
643,50 mln
643,50 mln
Net income
-1,74 mlrd
-1,74 mlrd
736,00 mln
736,00 mln
Net profit margin
-16,22%
-16,22%
8,62%
8,62%
Earnings per share
-
-
-
-
Interest and investment income
93,00 mln
93,00 mln
83,50 mln
83,50 mln
Interest expense
-445,50 mln
-445,50 mln
-426,50 mln
-426,50 mln
Net interest expenses
-352,50 mln
-352,50 mln
-343,00 mln
-343,00 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
1,79 mlrd
1,79 mlrd
1,39 mlrd
1,39 mlrd
Gain or loss from assets sale
11,00 mln
11,00 mln
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer